Immune-based combination therapy for metastatic kidney cancer

Nat Rev Nephrol. 2019 Jun;15(6):324-325. doi: 10.1038/s41581-019-0149-0.

Authors

Camillo Porta^{1

2}, Mimma Rizzo³

Affiliations

¹ Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. [email protected].
² Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy. [email protected].
³ Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.

PMID: 30992548
DOI: 10.1038/s41581-019-0149-0

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Axitinib
Carcinoma, Renal Cell*
Humans
Kidney Neoplasms*
Sunitinib

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Axitinib
avelumab
Sunitinib